The International Journal of Medical Discoveries (IJMD) is a peer-reviewed, open-access journal dedicated to advancing the understanding, innovation, and application of medical science. Our mission is to serve as a platform for the dissemination of cutting-edge research and discoveries that shape the future of healthcare and important medical discoveries worldwide.
Al-Azhar Scientific Medical Society, faculty of medicine, Al-Azhar University
EgyptDr. Eman Gamal El-Din Ezzat Helal is a Professor at Al Azhar University, Cairo, Egypt, with vast teaching experience in hematology, comparative physiology, and biochemistry. Holding a Ph.D. in Physiology, her research focused on mineralocorticoid activity in young chickens. Over her career, she has held positions from Demonstrator to Professor, contributing to the field. Prof. Helal is a member of esteemed societies including the Egyptian German Society and the Egyptian Society of Physiology, reflecting her dedication to advancing scientific knowledge.
Close
Receptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp
BelgiumDr. Stuart Maudsley currently holds the Odysseus Chair in Receptor Pharmacology and is also the Group Leader of the Receptor Biology Laboratory at the University of Antwerp. In addition to this, he is the Co-Founder of the therapeutic discovery start-up HeptOME. He has served as the Adjunct Director of the VIB Department of Molecular Genetics as well as Chair of the Department of Biomedical Science at the University of Antwerp. His research focuses on the age-dependent changes in receptor pharmacology associated with complex diseases driven by molecular gerontological signaling, e.g., neurodegenerative conditions such as Alzheimer’s disease and Frontotemporal dementia; cardiovascular disease; chronic kidney disease; diabetic pathology conditions; and multiple oncologies including triple-negative breast cancer. After gaining his Ph.D. as the Ackroyd Brother & Brown Research Fellow in Receptor Pharmacology from the University of Leeds, he received a Howard Hughes Medical Institute Fellowship Award to train with Professor Robert Lefkowitz (2012 Nobel Laureate in Chemistry) at Duke University. He was then recruited to be the youngest Principal Investigator of the Receptor Biology Section at the Medical Research Council Human Reproductive Sciences Unit at the University of Edinburgh in the U.K. After successfully developing a line of receptor-based novel prostate cancer therapeutics at the MRC, Dr. Stuart was next recruited to the National Institutes of Health (NIH) where I worked for the next decade as the Head of the Receptor Pharmacology Unit at the NIH-National Institute on Aging at the Johns Hopkins Medical School. In addition to this, he was also a lecturer in Molecular Gerontology at the Hopkins-affiliated Bloomberg School of Public Health.
Close